Kymera Therapeutics Inc. (KYMR)
NASDAQ · Healthcare
Kymera Therapeutics Inc. Operating Income 2019–2025
Kymera Therapeutics Inc. annual/quarterly operating income history and growth rate from 2019 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Kymera Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -84.2 M, a 13.07% increase year-over-year.
- Kymera Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -335.7 M, a 40.80% increase year-over-year.
- Kymera Therapeutics Inc. annual operating income for 2025 was -349.4 M, a 33.54% increase from 2024.
- Kymera Therapeutics Inc. annual operating income for 2024 was -261.6 M, a 58.06% increase from 2023.
- Kymera Therapeutics Inc. annual operating income for 2023 was -165.5 M, a 2.65% increase from 2022.
- Kymera Therapeutics Inc. annual operating income for 2022 was -161.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Kymera Therapeutics Inc. Operating Income — FAQ
Kymera Therapeutics Inc. (KYMR) operating income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Kymera Therapeutics Inc.'s operating income?
Kymera Therapeutics Inc. (KYMR) reported operating income of -$349M for fiscal 2025.
Where can I see KYMR's operating income history?
The chart and table above show Kymera Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.